-
1
-
-
2442704240
-
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
-
Abdalla EK, Vauthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann. Surg. 239(6), 818-825 (2004).
-
(2004)
Ann. Surg.
, vol.239
, Issue.6
, pp. 818-825
-
-
Abdalla, E.K.1
Vauthey, J.N.2
Ellis, L.M.3
-
2
-
-
0036104072
-
Trends in long-term survival following liver resection for hepatic colorectal metastases
-
Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg. 235(6), 759-766 (2002).
-
(2002)
Ann. Surg.
, vol.235
, Issue.6
, pp. 759-766
-
-
Choti, M.A.1
Sitzmann, J.V.2
Tiburi, M.F.3
-
3
-
-
4344615981
-
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)
-
Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann. Surg. 240(3), 438-447 (2004).
-
(2004)
Ann. Surg.
, vol.240
, Issue.3
, pp. 438-447
-
-
Fernandez, F.G.1
Drebin, J.A.2
Linehan, D.C.3
Dehdashti, F.4
Siegel, B.A.5
Strasberg, S.M.6
-
4
-
-
20944450851
-
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases
-
DOI 10.1097/01.sla.0000160703.75808.7d
-
Pawlik TM, Scoggins CR, Zorzi D et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann. Surg. 241(5), 715-722 (2005). (Pubitemid 40604917)
-
(2005)
Annals of Surgery
, vol.241
, Issue.5
, pp. 715-724
-
-
Pawlik, T.M.1
Scoggins, C.R.2
Zorzi, D.3
Abdalla, E.K.4
Andres, A.5
Eng, C.6
Curley, S.A.7
Loyer, E.M.8
Muratore, A.9
Mentha, G.10
Capussotti, L.11
Vauthey, J.-N.12
Choti, M.A.13
Adams, R.B.14
Bolton, J.S.15
Hemming, A.W.16
Cofer, J.B.17
Smythe, W.R.18
Clary, B.M.19
Vauthey, J.-N.20
more..
-
5
-
-
33644822617
-
Neoadjuvant chemotherapy for metastatic colon cancer: A cautionary note
-
DOI 10.1200/JCO.2005.03.2334
-
Bilchik AJ, Poston G, Curley SA et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J. Clin. Oncol. 23(36), 9073-9078 (2005). (Pubitemid 46260162)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.36
, pp. 9073-9078
-
-
Bilchik, A.J.1
Poston, G.2
Curley, S.A.3
Strasberg, S.4
Saltz, L.5
Adam, R.6
Nordlinger, B.7
Rougier, P.8
Rosen, L.S.9
-
6
-
-
0347481231
-
Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy
-
DOI 10.1016/j.gassur.2003.08.005
-
Parikh AA, Gentner B, Wu TT, Curley SA, Ellis LM, Vauthey JN. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J. Gastrointest. Surg. 7(8), 1082-1088 (2003). (Pubitemid 37526731)
-
(2003)
Journal of Gastrointestinal Surgery
, vol.7
, Issue.8
, pp. 1082-1088
-
-
Parikh, A.A.1
Gentner, B.2
Wu, T.-T.3
Curley, S.A.4
Ellis, L.M.5
Vauthey, J.-N.6
-
7
-
-
10744231437
-
Impact of steatosis on perioperative outcome following hepatic resection
-
DOI 10.1016/j.gassur.2003.09.012
-
Kooby DA, Fong Y, Suriawinata A et al. Impact of steatosis on perioperative outcome following hepatic resection. J. Gastrointest. Surg. 7(8), 1034-1044 (2003). (Pubitemid 37524071)
-
(2003)
Journal of Gastrointestinal Surgery
, vol.7
, Issue.8
, pp. 1034-1044
-
-
Kooby, D.A.1
Fong, Y.2
Suriawinata, A.3
Gonen, M.4
Allen, P.J.5
Klimstra, D.S.6
DeMatteo, R.P.7
D'Angelica, M.8
Blumgart, L.H.9
Jarnagin, W.R.10
-
8
-
-
11144354740
-
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
-
DOI 10.1093/annonc/mdh095
-
Rubbia-Brandt L, Audard V, Sartoretti P et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann. Oncol. 15(3), 460-466 (2004). (Pubitemid 38444550)
-
(2004)
Annals of Oncology
, vol.15
, Issue.3
, pp. 460-466
-
-
Rubbia-Brandt, L.1
Audard, V.2
Sartoretti, P.3
Roth, A.D.4
Brezault, C.5
Le Charpentier, M.6
Dousset, B.7
Morel, P.8
Soubrane, O.9
Chaussade, S.10
Mentha, G.11
Terris, B.12
-
9
-
-
33750957147
-
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases
-
DOI 10.1200/JCO.2006.05.8156
-
Aloia T, Sebagh M, Plasse M et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J. Clin. Oncol. 24(31), 4983-4990 (2006). (Pubitemid 46631400)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.31
, pp. 4983-4990
-
-
Aloia, T.1
Sebagh, M.2
Plasse, M.3
Karam, V.4
Levi, F.5
Giacchetti, S.6
Azoulay, D.7
Bismuth, H.8
Castaing, D.9
Adam, R.10
-
10
-
-
33646457231
-
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
-
DOI 10.1200/JCO.2005.05.3074
-
Vauthey JN, Pawlik TM, Ribero D et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol. 24(13), 2065-2072 (2006). (Pubitemid 46622116)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.13
, pp. 2065-2072
-
-
Vauthey, J.-N.1
Pawlik, T.M.2
Ribero, D.3
Wu, T.-T.4
Zorzi, D.5
Hoff, P.M.6
Xiong, H.Q.7
Eng, C.8
Lauwers, G.Y.9
Mino-Kenudson, M.10
Risio, M.11
Muratore, A.12
Capussotti, L.13
Curley, S.A.14
Abdalla, E.K.15
-
11
-
-
34548513652
-
Final results of the EORTC Intergroup randomized Phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases
-
Nordlinger B, Sorbye H, Collette L et al. Final results of the EORTC Intergroup randomized Phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J. Clin. Oncol. 25, 18S (2007).
-
(2007)
J. Clin. Oncol.
, vol.25
-
-
Nordlinger, B.1
Sorbye, H.2
Collette, L.3
-
12
-
-
67650970110
-
The case for selective use of pre-operative chemotherapy for hepatic colorectal metastases: More is not always better
-
Karakousis G, Fong Y. The case for selective use of pre-operative chemotherapy for hepatic colorectal metastases: more is not always better. Ann. Surg. Oncol. 16(8), 2086-2088 (2009).
-
(2009)
Ann. Surg. Oncol.
, vol.16
, Issue.8
, pp. 2086-2088
-
-
Karakousis, G.1
Fong, Y.2
-
13
-
-
4644320061
-
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival
-
DOI 10.1097/01.sla.0000141198.92114.f6
-
Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg. 240(4), 644-657 (2004). (Pubitemid 39281287)
-
(2004)
Annals of Surgery
, vol.240
, Issue.4
, pp. 644-658
-
-
Adam, R.1
Delvart, V.2
Pascal, G.3
Valeanu, A.4
Castaing, D.5
Azoulay, D.6
Giacchetti, S.7
Paule, B.8
Kunstlinger, F.9
Ghemard, O.10
Levi, F.11
Bismuth, H.12
Wanebo, H.J.13
Fitzgibbons Jr., R.J.14
Strasberg, S.M.15
Easter, D.W.16
-
14
-
-
0036257307
-
Biochemical and cellular mechanisms of toxic liver injury
-
DOI 10.1055/s-2002-30100
-
Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Semin. Liver Dis. 22(2), 137-144 (2002). (Pubitemid 34496467)
-
(2002)
Seminars in Liver Disease
, vol.22
, Issue.2
, pp. 137-144
-
-
Kaplowitz, N.1
-
15
-
-
28844459409
-
Non-alcoholic steatohepatitis: From cell biology to clinical practice
-
DOI 10.1016/j.jhep.2005.09.002, PII S0168827805006100
-
Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J. Hepatol. 44(1), 197-208 (2006). (Pubitemid 41772535)
-
(2006)
Journal of Hepatology
, vol.44
, Issue.1
, pp. 197-208
-
-
Cortez-Pinto, H.1
De Moura, M.C.2
Day, C.P.3
-
16
-
-
0036125693
-
Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease)
-
DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 22(1), 27-42 (2002).
-
(2002)
Semin. Liver Dis.
, vol.22
, Issue.1
, pp. 27-42
-
-
Deleve, L.D.1
Shulman, H.M.2
McDonald, G.B.3
-
17
-
-
22144463566
-
The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells
-
DOI 10.1159/000085617
-
Grivicich I, Regner A, da Rocha AB et al. The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells. Chemotherapy 51(2-3), 93-102 (2005). (Pubitemid 40981065)
-
(2005)
Chemotherapy
, vol.51
, Issue.2-3
, pp. 93-102
-
-
Grivicich, I.1
Regner, A.2
Da Rocha, A.B.3
Kayser, G.B.4
Schunemann, D.P.5
Grass, L.B.6
Alves, P.A.G.7
Henriques, J.A.P.8
Schwartsmann, G.9
-
18
-
-
32844458032
-
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
-
DOI 10.1016/j.mito.2005.10.004, PII S1567724905001364
-
Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6(1), 1-28 (2006). (Pubitemid 43250588)
-
(2006)
Mitochondrion
, vol.6
, Issue.1
, pp. 1-38
-
-
Begriche, K.1
Igoudjil, A.2
Pessayre, D.3
Fromenty, B.4
-
19
-
-
63149185244
-
Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: Prevention by thiol group protecting agents
-
Custodio JB, Cardoso CM, Santos MS, Almeida LM, Vicente JA, Fernandes MA. Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: prevention by thiol group protecting agents. Toxicology 259(1-2), 18-24 (2009).
-
(2009)
Toxicology
, vol.259
, Issue.1-2
, pp. 18-24
-
-
Custodio, J.B.1
Cardoso, C.M.2
Santos, M.S.3
Almeida, L.M.4
Vicente, J.A.5
Fernandes, M.A.6
-
20
-
-
29244492044
-
Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases [1]
-
DOI 10.1016/j.jamcollsurg.2005.09.010, PII S1072751505014407
-
Rubbia-Brandt L, Mentha G, Terris B. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J. Am. Coll. Surg. 202(1), 199-200 (2006). (Pubitemid 41831492)
-
(2006)
Journal of the American College of Surgeons
, vol.202
, Issue.1
, pp. 199-200
-
-
Rubbia-Brandt, L.1
Mentha, G.2
Terris, B.3
-
21
-
-
19744365905
-
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases
-
DOI 10.1016/j.jamcollsurg.2005.01.024, PII S1072751505001195
-
Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J. Am. Coll. Surg. 200(6), 845-853 (2005). (Pubitemid 40744790)
-
(2005)
Journal of the American College of Surgeons
, vol.200
, Issue.6
, pp. 845-853
-
-
Fernandez, F.G.1
Ritter, J.2
Goodwin, J.W.3
Linehan, D.C.4
Hawkins, W.G.5
Strasberg, S.M.6
-
22
-
-
53549133451
-
Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases
-
Kandutsch S, Klinger M, Hacker S, Wrba F, Gruenberger B, Gruenberger T. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. Eur. J. Surg. Oncol. 34(11), 1231-1236 (2008).
-
(2008)
Eur. J. Surg. Oncol.
, vol.34
, Issue.11
, pp. 1231-1236
-
-
Kandutsch, S.1
Klinger, M.2
Hacker, S.3
Wrba, F.4
Gruenberger, B.5
Gruenberger, T.6
-
23
-
-
30144435398
-
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
-
DOI 10.1097/01.sla.0000193603.26265.c3
-
Karoui M, Penna C, Amin-Hashem M et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann. Surg. 243(1), 1-7 (2006). (Pubitemid 43054046)
-
(2006)
Annals of Surgery
, vol.243
, Issue.1
, pp. 1-7
-
-
Karoui, M.1
Penna, C.2
Amin-Hashem, M.3
Mitry, E.4
Benoist, S.5
Franc, B.6
Rougier, P.7
Nordlinger, B.8
-
24
-
-
14644399212
-
Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: A real entity (multiple letters) [1]
-
DOI 10.1093/annonc/mdi040
-
Sebagh M, Plasse M, Levi F, Adam R. Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity? Ann. Oncol. 16(2), 331 (2005). (Pubitemid 40309318)
-
(2005)
Annals of Oncology
, vol.16
, Issue.2
, pp. 331-333
-
-
Sebagh, M.1
Plasse, M.2
Levi, F.3
Adam, R.4
Rubbia-Brandt, L.5
Mentha, G.6
Dousset, B.7
Terris, B.8
-
25
-
-
37549068554
-
Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy
-
Nakano H, Oussoultzoglou E, Rosso E et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann. Surg. 247(1), 118-124 (2008).
-
(2008)
Ann. Surg.
, vol.247
, Issue.1
, pp. 118-124
-
-
Nakano, H.1
Oussoultzoglou, E.2
Rosso, E.3
-
26
-
-
58949094415
-
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management
-
Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49(1), 306-317 (2009).
-
(2009)
Hepatology
, vol.49
, Issue.1
, pp. 306-317
-
-
Vuppalanchi, R.1
Chalasani, N.2
-
27
-
-
33846309211
-
Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes
-
DOI 10.1002/jso.20632
-
Sahajpal A, Vollmer CM Jr, Dixon E et al. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J. Surg. Oncol. 95(1), 22-27 (2007). (Pubitemid 46122713)
-
(2007)
Journal of Surgical Oncology
, vol.95
, Issue.1
, pp. 22-27
-
-
Sahajpal, A.1
Vollmer Jr., C.M.2
Dixon, E.3
Chan, E.K.4
Wei, A.5
Cattral, M.S.6
Taylor, B.R.7
Grant, D.R.8
Greig, P.D.9
Gallinger, S.10
-
28
-
-
34347234594
-
Preoperative chemotherapy for colorectal liver metastases: Impact on hepatic histology and postoperative outcome
-
Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J. Gastrointest. Surg. 11(7), 860-868 (2007).
-
(2007)
J. Gastrointest. Surg.
, vol.11
, Issue.7
, pp. 860-868
-
-
Pawlik, T.M.1
Olino, K.2
Gleisner, A.L.3
Torbenson, M.4
Schulick, R.5
Choti, M.A.6
-
29
-
-
37048998995
-
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases
-
DOI 10.1002/cncr.23099
-
Ribero D, Wang H, Donadon M et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 110(12), 2761-2767 (2007). (Pubitemid 350250347)
-
(2007)
Cancer
, vol.110
, Issue.12
, pp. 2761-2767
-
-
Ribero, D.1
Wang, H.2
Donadon, M.3
Zorzi, D.4
Thomas, M.B.5
Eng, C.6
Chang, D.Z.7
Curley, S.A.8
Abdalla, E.K.9
Ellis, L.M.10
Vauthey, J.-N.11
-
30
-
-
55949084563
-
Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases
-
Kesmodel SB, Ellis LM, Lin E et al. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J. Clin. Oncol. 26(32), 5254-5260 (2008).
-
(2008)
J. Clin. Oncol.
, vol.26
, Issue.32
, pp. 5254-5260
-
-
Kesmodel, S.B.1
Ellis, L.M.2
Lin, E.3
-
31
-
-
33846603686
-
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: A matched case-control study
-
DOI 10.1245/s10434-006-9074-0
-
D'Angelica M, Kornprat P, Gonen M et al. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann. Surg. Oncol. 14(2), 759-765 (2007). (Pubitemid 46175324)
-
(2007)
Annals of Surgical Oncology
, vol.14
, Issue.2
, pp. 759-765
-
-
D'Angelica, M.1
Kornprat, P.2
Gonen, M.3
Chung, K.-Y.4
Jarnagin, W.R.5
DeMatteo, R.P.6
Fong, Y.7
Kemeny, N.8
Blumgart, L.H.9
Saltz, L.B.10
-
32
-
-
30144445201
-
Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation
-
DOI 10.1097/01.rct.0000193818.31749.84
-
Oliva MR, Mortele KJ, Segatto E et al. Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J. Comput. Assist. Tomogr. 30(1), 37-43 (2006). (Pubitemid 43052296)
-
(2006)
Journal of Computer Assisted Tomography
, vol.30
, Issue.1
, pp. 37-43
-
-
Oliva, M.R.1
Mortele, K.J.2
Segatto, E.3
Glickman, J.N.4
Erturk, S.M.5
Ros, P.R.6
Silverman, S.G.7
-
33
-
-
0031781467
-
Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer
-
Peppercorn PD, Reznek RH, Wilson P, Slevin ML, Gupta RK. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br. J. Cancer 77(11), 2008-2011 (1998). (Pubitemid 28254648)
-
(1998)
British Journal of Cancer
, vol.77
, Issue.11
, pp. 2008-2011
-
-
Peppercorn, P.D.1
Reznek, R.H.2
Wilson, P.3
Slevin, M.L.4
Gupta, R.K.5
-
34
-
-
30144440445
-
CASH (chemotherapy-associated steatohepatitis) costs
-
DOI 10.1097/01.sla.0000193599.57858.9b
-
Fong Y, Bentrem DJ. CASH (chemotherapy-associated steatohepatitis) costs. Ann. Surg. 243(1), 8-9 (2006). (Pubitemid 43054047)
-
(2006)
Annals of Surgery
, vol.243
, Issue.1
, pp. 8-9
-
-
Fong, Y.1
Bentrem, D.J.2
-
35
-
-
40749149728
-
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial
-
DOI 10.1016/S0140-6736(08)60455-9, PII S0140673608604559
-
Nordlinger B, Sorbye H, Glimelius B et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617), 1007-1016 (2008). (Pubitemid 351392040)
-
(2008)
The Lancet
, vol.371
, Issue.9617
, pp. 1007-1016
-
-
Nordlinger, B.1
Sorbye, H.2
Glimelius, B.3
Poston, G.J.4
Schlag, P.M.5
Rougier, P.6
Bechstein, W.O.7
Primrose, J.N.8
Walpole, E.T.9
Finch-Jones, M.10
Jaeck, D.11
Mirza, D.12
Parks, R.W.13
Collette, L.14
Praet, M.15
Bethe, U.16
Van Cutsem, E.17
Scheithauer, W.18
Gruenberger, T.19
-
36
-
-
40549124674
-
The extract of Prunus persica flesh (PPFE) attenuates chemotherapy-induced hepatotoxicity in mice
-
DOI 10.1002/ptr.2296
-
Lee CK, Park KK, Hwang JK, Lee SK, Chung WY. The extract of Prunus persica flesh (PPFE) attenuates chemotherapy-induced hepatotoxicity in mice. Phytother. Res. 22(2), 223-227 (2008). (Pubitemid 351363242)
-
(2008)
Phytotherapy Research
, vol.22
, Issue.2
, pp. 223-227
-
-
Chang, K.L.1
Kwang, K.P.2
Jae, K.H.3
Sang, K.L.4
Won, Y.C.5
-
37
-
-
46749133563
-
The pericarp extract of Prunus persica attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in mice
-
DOI 10.1089/jmf.2007.545
-
Lee CK, Park KK, Hwang JK, Lee SK, Chung WY. The pericarp extract of Prunus persica attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in mice. J. Med. Food 11(2), 302-306 (2008). (Pubitemid 351948168)
-
(2008)
Journal of Medicinal Food
, vol.11
, Issue.2
, pp. 302-306
-
-
Lee, C.K.1
Park, K.-K.2
Hwang, J.-K.3
Lee, S.K.4
Chung, W.-Y.5
-
38
-
-
62349101530
-
Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases
-
Brouquet A, Benoist S, Julie C et al. Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 145(4), 362-371 (2009).
-
(2009)
Surgery
, vol.145
, Issue.4
, pp. 362-371
-
-
Brouquet, A.1
Benoist, S.2
Julie, C.3
-
39
-
-
33751545838
-
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
-
DOI 10.1056/NEJMoa060326
-
Belfort R, Harrison SA, Brown K et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355(22), 2297-2307 (2006). (Pubitemid 44837778)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.22
, pp. 2297-2307
-
-
Belfort, R.1
Harrison, S.A.2
Brown, K.3
Darland, C.4
Finch, J.5
Hardies, J.6
Balas, B.7
Gastaldelli, A.8
Tio, F.9
Pulcini, J.10
Berria, R.11
Ma, J.Z.12
Dwivedi, S.13
Havranek, R.14
Fincke, C.15
DeFronzo, R.16
Bannayan, G.A.17
Schenker, S.18
Cusi, K.19
|